Skip to main content

Proactive news headlines including Buru Energy, Hawsons Iron, Red River Resources and ioneer Ltd

Written by Customer Service on . Posted in Mergers And Acquisitions.

Sydney, June 30, 2022 (GLOBE NEWSWIRE) — Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

  • Buru Energy Ltd (ASX:BRU) is expecting record revenue from its share of the pending sale of an Ungani oil cargo, with 75,000 barrels gross due to be lifted from Wyndham Port in Western Australia by crude tanker Aris today. Click here
  • Hawsons Iron Ltd (ASX:HIO) has advised that analytical work on its mineral resources estimate update has not been completed on time due to the cumulative delaying impact of wet weather, COVID and additional time required to process the necessary data. Click here
  • Red River Resources Ltd (ASX:RVR) has received encouraging results from ongoing mineral resource delineation drilling at Liontown deposit, part of its Thalanga Operations in northern Queensland. Click here
  • ioneer Ltd (ASX:INR, OTC:GSCCF) is progressing its secondary listing on the Nasdaq Stock Market in the US under an American Depositary Receipt (ADR) program. Click here
  • Highfield Resources Ltd (ASX:HFR) is trading higher after reaching a pivotal point at its flagship Muga Potash Mine in Spain with initial construction activities underway. Click here
  • Creso Pharma Ltd (ASX:CPH, OTCQB:COPHF) has secured a non-binding, non-exclusive Heads of Agreement (HoA) with leading pharma and healthcare products company, China Chemical & Pharmaceutical Co., Ltd., which will introduce Sierra Sage Herbs LLC products to the Taiwanese animal healthcare market. Click here
  • American Rare Earths Ltd (ASX:ARR) US-based subsidiary Western Rare Earths is the sole industry member invited to a research and development consortium led by Lawrence Livermore National Laboratory (LLNL). Click here
  • Volt Resources Ltd (ASX:VRC) has received firm commitments to raise $2 million in a share placement with the intention of recommencing graphite production in Ukraine and advancing downstream processing initiatives. Click here
  • SensOre Ltd (ASX:S3N) has passed an important milestone having recently completed a major update involving the cleaning and ingestion of valuable geochemical data into its hyperdimensional Data Cube. Click here
  • Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) is making good progress with its two pipeline assets, paxalisib and EVT801, with the latter having cleared third dose level and is recruiting well. Click here
  • Race Oncology Ltd (ASX:RAC) is trading higher after releasing positive interim results from a preclinical cardioprotection program undertaken in collaboration with researchers from the University of Newcastle that highlighted Zantrene’s protective function for the hearts of mice given chemotherapy drugs. Click here
  • Allup Silica Ltd (ASX:APS) has completed a resource upgrade for the Sparkler A Silica Sands Exploration Project in Western Australia, which provides encouragement for further work to reduce iron content and increase the potential purity of the final processed products. Click here
  • Blue Star Helium Ltd (ASX:BNL, OTC:BSNLF) has bolstered its US exploration and development expertise with the appointment of Peter Kondrat as chief operating officer, to begin immediately from his home base in Colorado. Click here
  • Cooper Metals Ltd (ASX:CPM) has identified several electromagnetic conductors potentially favourable for iron-sulphide copper-gold (ISCG) mineralisation in its maiden airborne electromagnetic survey over the Mt Isa East Copper-Gold Project in Queensland. Click here
  • Miramar Resources Ltd (ASX:M2R) has received multiple, high-grade gold results from aircore drilling at its 80%-owned Gidji JV Project in WA. Click here
  • Westar Resources Ltd (ASX:WSR) has identified multiple high-priority, drill-read gold targets at the Gidgee North Project in WA following a detailed technical review of extensive geological datasets. Click here
  • Paradigm Biopharmaceuticals Ltd (ASX:PAR) has received official approval from IP Australia for a patent application covering the treatment of bone marrow pathologies with polysulfated polysaccharides under Australian application number 2021201198. Click here

About Proactive

  • Proactive is a unique tech-enabled platform providing companies globally with a comprehensive investor engagement solution across their business lifecycle.
  • With six offices on three continents, Proactive works with innovative growth companies quoted on the world’s major stock exchanges, helping executives to engage intelligently with investors.
  • In 2020, Proactive featured in 809 million search results, our content was viewed over 165 million times and our readers spent over 10 million hours on our websites. Proactive has produced over 300,000 articles and 20,000 executive interviews since it was established in 2006.

For more information on how Proactive can help you make a difference, email us at action@proactiveinvestors.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.